Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Hirsch currently holds 28,650 shares of Poseida Therapeutics, Inc. (PSTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Hirsch has been a net buyer of PSTX stock. They have purchased $25.9M and sold $18.1M worth of shares.
David Hirsch's most recent insider trade was on May 23, 2024, when they sold 28,650 shares at $0.00 per share.
David Hirsch serves as Executive at Poseida Therapeutics, Inc. (PSTX). They have executed 34 insider transactions totaling $44.0M over their tenure at the company.
David Hirsch holds the position of Executive at Poseida Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
David Hirsch has shown a buying trading pattern, with $25.9M in total purchases and $18.1M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by David Hirsch was on Dec 8, 2017, when they sold $17.0M worth of COLL shares. This transaction involved 980,350 shares at $17.34 per share.
David Hirsch currently owns 28,650 shares of Poseida Therapeutics, Inc. (PSTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Hirsch's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Hirsch has 34 Form 4 filings on record as an insider at Poseida Therapeutics, Inc..
Set alerts for David Hirsch and 40,000+ other insiders.